Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Veure altres versions (1)

Primaquine (PQ) kills Plasmodium vivax hypnozoites but can cause severe hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. We conducted two systematic reviews. The first used data from clinical trials to determine the variety of definitions and frequency of hematological...

Descripció completa

Dades bibliogràfiques
Autors principals:	Yilma, D, Groves, ES, Brito-Sousa, JD, Monteiro, WM, Chu, C, Thriemer, K, Commons, RJ, Lacerda, MVG, Price, RN, Douglas, NM
Format:	Journal article
Idioma:	English
Publicat:	American Society of Tropical Medicine and Hygiene 2023

Ítems similars

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
per: Yilma, D, et al.
Publicat: (2021)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
per: Price, RN, et al.
Publicat: (2018)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
per: John, G, et al.
Publicat: (2012)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
per: Watson, JA, et al.
Publicat: (2022)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
per: Watson, J, et al.
Publicat: (2018)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
per: Abla, N, et al.
Publicat: (2024)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
per: Watson, JA, et al.
Publicat: (2024)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
per: Taylor, WRJ, et al.
Publicat: (2023)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
per: Taylor, WR, et al.
Publicat: (2021)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
per: Rahmalia, A, et al.
Publicat: (2019)

Primaquine-induced severe hemolysis in the absence of concomitant malaria: effects on G6PD activity and renal function
per: Douglas, NM, et al.
Publicat: (2022)

Primaquine for plasmodium vivax malaria treatment – authors' reply
per: Price, RN, et al.
Publicat: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
per: Setyadi, A, et al.
Publicat: (2019)

Progress towards safer and more effective radical cure of Plasmodium vivax
per: Price, RN
Publicat: (2024)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
per: Poespoprodjo, JR, et al.
Publicat: (2021)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
per: Taylor, WRJ, et al.
Publicat: (2019)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
per: Pukrittayakamee, S, et al.
Publicat: (2010)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
per: Commons, RJ, et al.
Publicat: (2020)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
per: Llanos-Cuentas, A, et al.
Publicat: (2019)

Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.
per: Fryauff, D, et al.
Publicat: (1997)

Evidence uptake is only part of the process: stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria
per: Ruwanpura, VSH, et al.
Publicat: (2024)

Improving the radical cure of Plasmodium vivax malaria.
per: Price, R
Publicat: (2014)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
per: Thriemer, K, et al.
Publicat: (2020)

Plasmodium vivax in the era of the shrinking P. falciparum map
per: Price, RN, et al.
Publicat: (2020)

A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
per: Sadhewa, A, et al.
Publicat: (2023)

Strategies for improving radical cure in P. vivax malaria
per: John, G
Publicat: (2012)

Declining burden of plasmodium vivax in a population in Northwestern Thailand from 1995 to 2016 before comprehensive primaquine prescription for radical cure
per: Chu, CS, et al.
Publicat: (2019)

Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
per: Ruwanpura, VSH, et al.
Publicat: (2021)

Primaquine induced haemolysis in G6PD heterozygous females treated for the radical cure of Plasmodium vivax malaria: a nested cohort study
per: Chu, C, et al.
Publicat: (2017)

Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
per: Abreha, T, et al.
Publicat: (2015)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
per: Rahmalia, A, et al.
Publicat: (2023)

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
per: Thriemer, K, et al.
Publicat: (2022)

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
per: Fadilah, I, et al.
Publicat: (2024)

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
per: Commons, RJ, et al.
Publicat: (2023)

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
per: Mehdipour, P, et al.
Publicat: (2023)

Single-dose radical cure of Plasmodium vivax: a step closer.
per: Price, R, et al.
Publicat: (2014)

Single-dose radical cure of Plasmodium vivax: A step closer
per: Price, R, et al.
Publicat: (2014)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
per: Rajasekhar, M, et al.
Publicat: (2023)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
per: Poespoprodjo, Jeanne Rini, et al.
Publicat: (2022)

Challenges for achieving safe and effective radical cure of P. vivax – a round table discussion of the APMEN Vivax Working Group
per: Thriemer, K, et al.
Publicat: (2017)